Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement.

Nerea Lopetegui LiaDanai DimaDavid Scott BuchbergerAnirudh YalamanchaliBennett OsantowskiMariah OndeckRobert Roman LorenzBrandon PrendesJamie KuEric D LamarreJoseph ScharpfNatalie Lea SilverLarisa SchwartzmanJessica Lyn GeigerNeil McIver WoodyShauna Rosalie CampbellShlomo A KoyfmanEmrullah Yilmaz

Published in: Head & neck (2023)

In this cohort, IO showed clinical response in 83% of patients, indicating IO can be an effective monotherapy, reserving RT for instances of local failure after IO.

Keyphrases

squamous cell carcinoma
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
clinical trial
open label
radiation therapy
combination therapy